Misinformation, limited understanding of biosimilars, and inconsistent insurance policies only add to the confusion.
Shubha Bhat, PharmD, MS
Advertisement
Articles by Shubha Bhat, PharmD, MS
Advertisement
Latest Updated Articles
Specialty Pharmacists Reduce Treatment Interruptions in Inflammatory Bowel Disease | ASHP Midyear 2025Published: December 7th 2025 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Congressional Spending Bill to Include Key PBM Contracting Reform
2
Meeting at the Crossroads: The Role and Impact of PBMs and BOPs on Pharmacists
3
Pharma, OTC Supplement Are Markets Expected to Grow Billions Come 2032
4
Q&A: New Medicare Drug Prices Proving Detrimental to Pharmacy Cashflow
5